Investors lost 37% by missing this ONE signal 😵Read now

3 Stocks To Watch In The Coming Week: FedEx, Nike, Pfizer

Published 12/13/2020, 07:26 AM

After a week brimming with IPO euphoria, which sent shares of newly listed Airbnb (NASDAQ:ABNB) and DoorDash (NYSE:DASH) soaring, investors might now turn their focus back to the Congressional stimulus package which has so far failed to gain the full political backing necessary for it to be enacted.

Both the Dow and S&P 500 posted their first weekly declines in three weeks, losing 0.6% and 1%, respectively. The NASDAQ dropped 0.7% for the week.

These pullbacks came as politicians continued their negotiations over a coronavirus relief package. Lawmakers are trying to pass a bill before the end of 2020, but disagreements over state and local stimulus, unemployment assistance and the size of stimulus checks still persists, according to media reports. Without fresh fiscal aid, millions of Americans could lose unemployment benefits in the new year. 

Amid this uncertainty, investors will also be getting the latest quarterly reports from some of the largest U.S. companies which could provide additional insight into consumers’ behavior during the COVID-19 pandemic which continues to spread. Below are mega cap stocks we'll be focusing on during the upcoming week:

1. FedEx

The world’s largest parcel delivery service, FedEx (NYSE:FDX), will report fiscal 2021, second quarter earnings after the market closes on Thursday, Dec. 17. On average, analysts are expecting earnings per share of $3.81 on sales of $19.27 billion.

FDX Weekly TTM

FedEx’s earnings, which come almost a month earlier than the majority of U.S. companies, are closely watched since the delivery business is considered a proxy for the global economy. The latest communications from the Memphis, Tennessee-based company show that its business is booming as it caters to the accelerating, pandemic-fueled demand.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

With digital ordering increasingly becoming the default option for millions of people stuck in their homes due to the coronavirus outbreak, FedEx’s ground deliveries are swelling.

Chief Marketing Officer Brie Carere told Bloomberg News in September that FedEx expects the U.S. market will reach 100 million packages a day by 2023, three years earlier than it had previously anticipated. 

Due to this momentum, FedEx shares have soared about 90% this year, closing at $289.47 on Friday. The company's latest guidance might offer some clues on how long this boom will last and whether this is the beginning of a long-term trend.

2. Nike

Nike (NYSE:NKE) will release its second quarter fiscal 2021 earnings on Friday, Dec. 18, after the market close. On average, analysts are expecting the sportswear giant to report $0.62 a share profit on sales of $10.55 billion.

NKE Weekly TTM

Expectations are that Nike will report very strong numbers with its physical stores opening and its direct-to-consumer business booming. Based on these hopes, investors sent Nike shares to a record high last week, after they surged more than 35% this year. The stock closed on Friday at $137.41.

Nike’s strong brand and its digital strategy have positioned  the athletic footwear maker of Air Jordan sneakers, among other sports apparel, for long-term growth. The company returned to profit in its fiscal first quarter, and posted much better results than what analysts had predicted, despite widespread global lockdowns and the cancellation of sporting events.

3. Pfizer

Pfizer (NYSE:PFE) stock may see some activity after the drugmaker gained emergency use authorization in the U.S. on Friday for its COVID-19 vaccine. Buying shares of the companies that are developing vaccines against COVID-19 has been a great bet this year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

PFE Weekly

Some of the leading candidates in the race to beat the deadly virus have seen the value of their stocks more than double in just a few weeks.

The Food and Drug Administration’s decision to authorize use of the vaccine developed by Pfizer and German partner BioNTech (NASDAQ:BNTX) will now set in motion a complicated immunization drive that will launch across the country in coming days.

Gen. Gustave F. Perna, the chief operating officer for the government vaccine program Operation Warp Speed, said at a news briefing Saturday that vaccines are being packaged and will arrive at the initial administration sites on Monday. Among the first to be inoculated will be health-care workers and seniors living in long-term care facilities. 

Pfizer shares are up 20% during the past three months, closing on Friday at $41.12, while BioNTech's stock has gained 94% during the same period.

Which stock should you buy in your very next trade?

AI computing powers are changing the stock market. Investing.com's ProPicks AI includes 6 winning stock portfolios chosen by our advanced AI. In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. Which stock will be the next to soar?

Unlock ProPicks AI

Latest comments

andrey galasDec 14, 2020, 11:30
Sill guy Farid... just buy in the moring calls on PFE and if you want to be safe sell at $45
Farid KhanDec 14, 2020, 00:04
Please me some one how i invest and how I get profits and the profit how much will be taken......
Javier Henche ChefDec 14, 2020, 03:27
This is not Wonderland, boy. If you dont know anything keep your money in your pockets.
Ma KisDec 14, 2020, 08:34
Farid, take a look at Value Investing strategy. I think for you it could be just what you need now. I suggest to read some books like "What Works on Wall Street" or any other Value Investing books. In general check the price ratios (P/B, P/FCF, P/S, PEG...), check the Ev/EBITDA and the earnings growth. buy those stock after doing some Tech. Analysis and don't forget to set Stop Losses.
Erik EsparzaDec 15, 2020, 12:17
Best comment right here...
Show all comments
Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.